| The intestinal microbiota in colorectal cancer H Tilg, TE Adolph, RR Gerner, AR Moschen Cancer cell 33 (6), 954-964, 2018 | 685 | 2018 |
| Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease C Grander, TE Adolph, V Wieser, P Lowe, L Wrzosek, B Gyongyosi, ... Gut 67 (5), 891-901, 2018 | 542 | 2018 |
| Lipocalin-2: a master mediator of intestinal and metabolic inflammation AR Moschen, TE Adolph, RR Gerner, V Wieser, H Tilg Trends in Endocrinology & Metabolism 28 (5), 388-397, 2017 | 322 | 2017 |
| Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations AR Moschen, RR Gerner, J Wang, V Klepsch, TE Adolph, SJ Reider, ... Cell host & microbe 19 (4), 455-469, 2016 | 301 | 2016 |
| Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease L Mayr, F Grabherr, J Schwärzler, I Reitmeier, F Sommer, T Gehmacher, ... Nature Communications 11 (1), 1775, 2020 | 172 | 2020 |
| Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity RH Mills, PS Dulai, Y Vázquez-Baeza, C Sauceda, N Daniel, RR Gerner, ... Nature microbiology 7 (2), 262-276, 2022 | 162 | 2022 |
| Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders A R Moschen, R R Gerner, H Tilg Current pharmaceutical design 16 (17), 1913-1920, 2010 | 159 | 2010 |
| Adult human and mouse ovaries lack DDX4-expressing functional oogonial stem cells H Zhang, S Panula, S Petropoulos, D Edsgärd, K Busayavalasa, L Liu, ... Nature medicine 21 (10), 1116-1118, 2015 | 141 | 2015 |
| NAD metabolism fuels human and mouse intestinal inflammation RR Gerner, V Klepsch, S Macheiner, K Arnhard, TE Adolph, C Grander, ... Gut 67 (10), 1813-1823, 2018 | 133 | 2018 |
| Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity AR Moschen, V Wieser, RR Gerner, A Bichler, B Enrich, P Moser, ... Journal of hepatology 59 (6), 1315-1322, 2013 | 113 | 2013 |
| Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease AR Moschen, S Geiger, R Gerner, H Tilg Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 690 (1 …, 2010 | 98 | 2010 |
| Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease V Wieser, P Tymoszuk, TE Adolph, C Grander, F Grabherr, B Enrich, ... Journal of Hepatology 64 (4), 872-880, 2016 | 93 | 2016 |
| Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver RR Gerner, V Wieser, AR Moschen, H Tilg Canadian journal of physiology and pharmacology 91 (11), 867-872, 2013 | 93 | 2013 |
| Lipocalin‐2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response M Nairz, A Schroll, D Haschka, S Dichtl, T Sonnweber, I Theurl, M Theurl, ... European journal of immunology 45 (11), 3073-3086, 2015 | 65 | 2015 |
| Liver complications in inflammatory bowel diseases V Wieser, R Gerner, AR Moschen, H Tilg Digestive diseases 31 (2), 233-238, 2013 | 53 | 2013 |
| Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut J Behnsen, H Zhi, AT Aron, V Subramanian, W Santus, MH Lee, ... Nature Communications 12 (1), 7016, 2021 | 47 | 2021 |
| A key role for Pre–B cell colony–enhancing factor in experimental hepatitis AR Moschen, R Gerner, A Schroll, T Fritz, A Kaser, H Tilg Hepatology 54 (2), 675-686, 2011 | 38 | 2011 |
| Iron at the host-microbe interface RR Gerner, SP Nuccio, M Raffatellu Molecular Aspects of Medicine 75, 100895, 2020 | 34 | 2020 |
| Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR 2 I Tancevski, M Nairz, K Duwensee, K Auer, A Schroll, C Heim, ... EMBO molecular medicine 6 (6), 810-820, 2014 | 32 | 2014 |
| Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis V Klepsch, RR Gerner, S Klepsch, WJ Olson, H Tilg, AR Moschen, G Baier, ... Gut 67 (8), 1434-1444, 2018 | 28 | 2018 |
AR MoschenProfessor of Medicine, Medical University Innsbruck在 i-med.ac.at 的电子邮件经过验证
